BGI Shenzhen Plans RMB 10 Billion Investment With Wuhan Biolake Project
This article was originally published in PharmAsia News
Executive Summary
Beijing Genomics Institute (BGI) Shenzhen recently announced plans to invest RMB 10 billion to develop a genomics industrial base in Wuhan's Biolake